The role of neurokinin B receptor antagonist, AZD4901 in the control of follicle development in healthy women with regular menstrual cycles

Trial Profile

The role of neurokinin B receptor antagonist, AZD4901 in the control of follicle development in healthy women with regular menstrual cycles

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2017

At a glance

  • Drugs MLE 4901 (Primary)
  • Indications Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2017 Results assessing role of AZD4901 in the control of follicle development in healthy women with regular menstrual cycles, were published in the Journal of Clinical Endocrinology and Metabolism.
    • 10 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top